AERIE PHARMACEUTICALS INC - COM (AERI)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
46,063,476
Share change
+2,123,901
Total reported value
$823,150,946
Put/Call ratio
176%
Price per share
$17.87
Number of holders
157
Value change
+$42,521,553
Number of buys
72
Number of sells
78

Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q1 2021

As of 31 Mar 2021, AERIE PHARMACEUTICALS INC - COM (AERI) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,063,476 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., BANK OF AMERICA CORP /DE/, Woodline Partners LP, PFM Health Sciences, LP, LOOMIS SAYLES & CO L P, MORGAN STANLEY, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, and SCHRODER INVESTMENT MANAGEMENT GROUP. This page lists 157 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.